Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells
- 31 December 2005
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 33 (12), 1521-1530
- https://doi.org/10.1016/j.exphem.2005.08.005
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Identification of CD14 as a predictor for leukemic dendritic cell differentiation in acute myeloid leukemia.Leukemia, 2003
- Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T CellsThe Journal of Experimental Medicine, 2003
- Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migrationBlood, 2003
- Retrovirus-mediated IL-7 expression in leukemic dendritic cells generated from primary acute myelogenous leukemias enhances their functional propertiesBlood, 2003
- Autologous and MHC class I–negative allogeneic tumor cells secreting IL-12 together cure disseminated A20 lymphomaBlood, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemiaLeukemia, 2002
- Stimulation of autologous proliferative and cytotoxic T-cell responses by “leukemic dendritic cells” derived from blast cells in acute myeloid leukemiaBlood, 2001
- Human acute myeloblastic leukemia cells differentiatein vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemiasEuropean Journal of Immunology, 1999
- Identification of human cancers deficient in antigen processing.The Journal of Experimental Medicine, 1993